Hematology 2026_ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2026) October 08 -10, 2026 | Tokyo, Japan has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
2nd Edition of International Summit on Hematology and Blood Disorders
October 8-10, 2026
Hematology 2026
Will be updated soon......
Will be updated soon......
Title : Arsenic Trioxide and Its Applications
Peng Zhang, Chief physician, China
Will be Updated Soon...
Title : Predictive Value of Routine Laboratory Tests for Early Death in Pediatric Hemophagocytic Lymphohistiocytosis Patients
Junxun Li, First Affiliated Hospital, Sun Yat-sen University, China
Background: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening systemic hyperinflammatory syndrome with high early mortality, especially in children. Early risk stratification is critical but hindered by non-routine predictive tests (e.g., sCD25, NK cell activity). T [....] » Read More
Title : Enhancing Thalassemia Gene Carrier Identification in Non-anemic Populations Using AI Erythrocyte Morphology Analysis and Machine Learning
Junxun Li, First Affiliated Hospital, Sun Yat-sen University, China
Background: Non-anemic thalassemia trait (TT) accounts for over 60% of TT cases in South China, yet remains challenging to identify due to absent anemia and the high cost of gold-standard genetic testing—especially in resource-limited regions. Traditional erythrocyte morph [....] » Read More
Title : Comprehensive symptom management and supportive nursing care in a preterm toddler undergoing HSCT for pyruvate kinase deficiency
Tran Thi Dung, Vinmec International Hospital, Vietnam
Background: Preterm toddlers undergoing hematopoietic stem cell transplantation (HSCT) face heightened vulnerability to treatment-related toxicities, infectious complications, and challenges in medication tolerance. Pyruvate kinase deficiency (PKD) further exacerbates anemia, tra [....] » Read More
Title : Eltrombopag added to combined immunosuppressive therapy IST in children with acquired severe aplastic anemia accelerates hematologic recovery and should be continued in the second course of IST
Olga Goronkova, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Russian Federation
Eltrombopag (ELTR) added to first-line standard immunosuppressive therapy (IST) has demonstrated efficacy in adult patients with severe aplastic anemia (SAA), but the data in children remains controversial. We extended our randomized prospective multicenter trial comparing effica [....] » Read More
Title : Acute intermittent porphyria: A neurological dilemma obscured by ubiquitous gastrointestinal presentation
Mayank Anand Singh, Mimer Medical College, India
Background: Acute intermittent porphyria (AIP) is a rare hepatic porphyria that may progress to severe neurovisceral complications if unrecognized. Its early clinical features often mimic common gastrointestinal (GI) disorders, resulting in frequent misdiagnoses and delayed treat [....] » Read More